Floatz logo

Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ucart20X22
B-Cell Non-Hodgkin Lymphoma
Cellectis S.A.P1/2CCC (48)
Umbilical Cord Derived Mesenchymal Stem Cells Exosomes
Frontotemporal Dementia
Ruijin HospitalP1/2CCC (48)
Umbilical Cord Derived Mesenchymal Stem Cells Exosomes
Alzheimer Disease
Xuanwu Hospital, BeijingP1/2CCC (48)
Umbilical Cord Mesenchymal Stem Cell
Inflammation Of Heart Layer
Nguyen Ton Ngoc HuynhP1/2CCC (48)
Umbilical Cord Mesenchymal Stem Cell
Inherited Lipid Metabolism Disorder
Nguyen Ton Ngoc HuynhP1/2CCC (48)
Urea
Metabolic Acidosis
University of California, San FranciscoP1/2CCC (48)
Uromitexan
Prostate Cancer
CuraCell TX ABP1/2CCC (48)
utd1
Her2-Receptor Negative Breast Cancer
Hunan Cancer HospitalP1/2CCC (48)
Valemetostat
Head And Neck Carcinoma
National Cancer Institute (NCI)P1/2CCC (48)
Valemetostat
Nasal Cavity And Paranasal Sinus Carcinoma
National Cancer Institute (NCI)P1/2CCC (48)
Valemetostat
Squamous Cell Lung Carcinoma
National Cancer Institute (NCI)P1/2CCC (48)
vb15010
Biliary Tract Cancer
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.P1/2CCC (48)
vb15010
Breast Cancer
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.P1/2CCC (48)
vbc101
Cancer
VelaVigo Bio IncP1/2CCC (48)
vbc103
Cancer
VelaVigo Bio IncP1/2CCC (48)
Vedolizumab
Non-Small Cell Lung Carcinoma
M.D. Anderson Cancer CenterP1/2CCC (48)
Vedolizumab
Cancer
M.D. Anderson Cancer CenterP1/2CCC (48)
Veliparib
Minimally Invasive Lung Adenocarcinoma
National Cancer Institute (NCI)P1/2CCC (48)
Venetoclax
Acute Disease
Molecular Partners AGP1/2CCC (48)
Venetoclax
Acute Myeloid Leukemia With CEBPA Somatic Mutations
The First Affiliated Hospital of Soochow UniversityP1/2CCC (48)
Venetoclax
Chronic Eosinophilic Leukemia
M.D. Anderson Cancer CenterP1/2CCC (48)
Venetoclax
Chronic Neutrophilic Leukemia
M.D. Anderson Cancer CenterP1/2CCC (48)
Venetoclax
Essential Thrombocythemia
M.D. Anderson Cancer CenterP1/2CCC (48)
Venetoclax
Myelofibrosis
Jacqueline Garcia, MDP1/2CCC (48)
Venetoclax
Myeloproliferative Neoplasm, Unclassifiable
M.D. Anderson Cancer CenterP1/2CCC (48)
Showing 2001 to 2025 of 6,308 assets
PreviousPage 81 of 253Next